SV Health Investors hits $265 million final close for first dedicated biotech fundraise
20 July 2020 – British Patient Capital provided a $65 million anchor investment for SV7 Impact Medicine Fund, which will aim to turn scientific breakthroughs into biotech companies producing high impact precision medicine drugs for poorly treated diseases.
